Hochschulschrift
Coadministration of tyrosine kinase inhibitors with Rottlerin in metastatic prostate cancer : = Co-Administration von Tyrosinkinase-Inhibitoren mit Rottlerin bei metastasierendem Prostatakrebs
- Weitere Titel
-
Co-Administration von Tyrosinkinase-Inhibitoren mit Rottlerin bei metastasierendem Prostatakrebs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
70 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Mainz, Univ., Diss., 2013
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:11 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice
Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation
Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring
Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback
Anti-Tumor-Immunität unter Tyrosinkinase-Inhibitor-Behandlung
Effekt kleinmolekularer Tyrosinkinase-Inhibitoren auf künstliches Herzgewebe
Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
Reduction of lithium induced interstitial fibrosis on co-administration with amiloride
Zanubrutinib (Brukinsa) : Bruton-Tyrosinkinase-Inhibitor bei Morbus Waldenström
HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir
Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice
Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation
Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring
Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback
Anti-Tumor-Immunität unter Tyrosinkinase-Inhibitor-Behandlung
Effekt kleinmolekularer Tyrosinkinase-Inhibitoren auf künstliches Herzgewebe
Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
Reduction of lithium induced interstitial fibrosis on co-administration with amiloride
Zanubrutinib (Brukinsa) : Bruton-Tyrosinkinase-Inhibitor bei Morbus Waldenström
HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir
Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice
Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation
Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring
Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback
Anti-Tumor-Immunität unter Tyrosinkinase-Inhibitor-Behandlung
Effekt kleinmolekularer Tyrosinkinase-Inhibitoren auf künstliches Herzgewebe
Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
Reduction of lithium induced interstitial fibrosis on co-administration with amiloride
Zanubrutinib (Brukinsa) : Bruton-Tyrosinkinase-Inhibitor bei Morbus Waldenström
HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir